National and Kapodistrian University of Athens
Μελέτη έκφρασης της ριβονουκλεοτιδικής αναγωγάσης σε ασθενείς με χρόνια λεμφοκυτταρική λευχαιμία
Abstract
dc:descriptionBackground: Ribonucleotide Reductase (RNR) converts ribonucleotides to deoxyribonucleotides required for DNA replication and repair. RNR consists of subunits RRM1 and RRM2. Imbalance of RNR activity and dNTPs’ pool leads to genomic instability. RNR expression is studied as a prognostic factor in several solid and hematological malignancies. RNR expression and its possible prognostic role in chronic lymphocytic leukemia (CLL) have not been investigated yet. Methods: Peripheral whole blood samples were collected from CLL patients. RNA extraction and reverse transcription were performed using standard protocols. RRM1 and RRM2 genes mRNA levels were expressed as RRM1/GAPDH and RRM2/GAPDH ratios. RRM1 gene promoter methylation was studied in a patients’ subgroup. Results: The study included 135 patients with CLL. RRM1 mRNA expression was significantly higher in patients without anemia (p=.026) and without lymphadenopathy (p=.005). ESR above 30 mm/h (p=.018), abnormal LDH levels (p=.022) and higher Rai stage (p=.019) were associated with lower levels of RRM1 mRNA. Deletion 17p was associated with higher RRM1 mRNA levels (p=.031). Higher RRM2 mRNA expression was found in patients without lymphadenopathy (p=.048) and Rai stage 0 (p=.025). The expression of RRM2 mRNA was increased in cases with Trisomy 12 (p=0.025). Methylated status of RRM1 gene promoter correlated with the presence of lymphadenopathy (p=.016). As a continuous variable, methylation levels correlated with presence of lymphadenopathy (p=.039) and Rai stage (p=,031). Methylated status correlated with about 4 times lower levels of RRM1 mRNA compared to unmethylated status (0.0123 vs 0.0465, p=.014), and with about 10 times lower levels of RRM2 mRNA (0.0038 vs 0.0397 for unmethylated status, p=.027). Conclusion: For the first time, mRNA levels of RRM1 and RRM2 genes are studied in patients with CLL. RRM1 and RRM2 genes mRNA higher levels found in deletion 17p and trisomy 12 cases indicate a methylation-depended mechanism as shown in previous studies. Including the association with Rai score, these results demonstrate RNR’s potential role as a prognostic factor and make it a probable therapeutic target.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2024
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Chatzidavid, Sevastianos
- Χατζηδαυίδ, Σεβαστιανός
Subjects
dc:subject × 14- Χρόνια λεμφοκυτταρική λευχαιμία
- Ριβονουκλεοτιδική αναγωγάση
- Ποσοτικοποίηση επιπέδων mRNA
- Μεθυλίωση υποκινητή
- Chronic lymphocytic leukemia
- Ribonucleotide reductase
- mRNA level quantification
- Promoter methylation
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Αιματολογία
- Clinical Medicine
- Medical and Health Sciences
- Hematology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/57652